U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07166263) titled 'Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer' on Sept. 03.
Brief Summary: This study will evaluate the safety and efficacy of NK510 in the treatment of relapsed and refractory advanced gastric cancer and colorectal cancer.NK510 will be administered by intravenous infusion for systemic therapy and intraperitoneal perfusion therapy. The safety and efficacy of this treatment will be evaluated.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Gastric Cancer (GC)
Colorectal Cancer
Intervention:
DRUG: NK510
NK510 will be administered through intravenous infusion, once a week for a to...